Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on Sodium Benzoate in Treatment Resistant Schizophrenia
NCT06340789Phase 2Recruiting
- Sponsor
- National Cheng Kung University Hospital
- Start
- Nov 2021
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium benzoate in schizophrenia, sponsored by National Cheng Kung University Hospital. Started Nov 2021; status: recruiting.
02
Drugs
sodium benzoate
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT06340789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06340789.